Nov 1, 2017 by Brian FeroldiFormFactor Continues to Execute, but Guidance Comes up ShortThe semiconductor testing and measurement specialist cranked out upbeat results yet again, but management issued guidance that fell short of estimates.
Nov 1, 2017 by Brian FeroldiHorizon Global Tops ExpectationsThe towing and trailering equipment company continues to perform well even in the face of hurricanes and a weak retail environment.
Oct 30, 2017 by Brian FeroldiThe 3 Best Diabetes Stocks to Buy in 2018Not all diabetes stocks are created equally.
Oct 30, 2017 by Brian FeroldiResMed's Sales and Profits RiseInvestors cheer the company's successful start to its fiscal year.
Oct 27, 2017 by Brian FeroldiCelgene At $100: Buy, Sell, or Hold?Shares have been devastated over the last month. Is right now a smart time to get in?
Oct 27, 2017 by Brian FeroldiWhy LeMaitre Vascular Inc. Is Plunging TodayTraders flee after the company reports lower-than-expected quarterly revenue and shares disappointing guidance. Does this drop represent a buying opportunity?
Oct 27, 2017 by Brian FeroldiQuintiles IMS Holdings Is Firing on All CylindersThe healthcare service and information provider impressed investors with its quarterly earnings.
Oct 27, 2017 by Brian FeroldiCullen/Frost Bankers Hits an All-Time HighInvestors in the Texas-based bank cheer after the company reports another quarter of upbeat results.
Oct 26, 2017 by Brian FeroldiAbiomed, Inc's Revenue and Profits Soar Yet AgainThe company continues to translate increased demand for its heart pumps into financial success.
Oct 26, 2017 by Brian FeroldiAlkermes Reports Mixed Results, Updates GuidanceRevenue growth of 21% wasn't enough to meet expectations, but expense control helped to save the day.
Oct 26, 2017 by Brian Feroldi3 Companies Tackling the Antibiotic-Resistant Bacteria CrisisParatek Corp., Nabriva Therapeutics, and Cempra all appear on course to bring new antibiotics to market soon. But which could be the best bet for your portfolio now?
Oct 23, 2017 by Brian FeroldiWhy MiMedx Group Inc. Is Sinking TodayShares tumble on little news -- are short-sellers behind the move?
Oct 23, 2017 by Brian FeroldiWhy PetMed Express Inc Is Soaring TodayTraders cheer better-than-expected earnings.
Oct 22, 2017 by Brian Feroldi5 Must-Read Quotes for Robotic Surgery InvestorsAll five are important, but the last one really took me by surprise.
Oct 22, 2017 by Brian Feroldi, Travis Hoium, and John Rosevear3 Dividend Stocks Ideal for Your Golden YearsLooking for reliable income after you retire? These three stocks will get you started.
Oct 20, 2017 by Brian FeroldiWhy Athenahealth Is Soaring TodayNews that layoffs are underway overshadowed mixed earnings results.
Oct 19, 2017 by Brian FeroldiHere's Why Corbus Pharmaceuticals Holdings Inc. Jumped Today Shares rally after the company reports encouraging results from a phase 2 trial.
Oct 18, 2017 by Brian FeroldiWhy Endocyte Is Rallying TodayShares spike on no news, but that happens in the land of small-cap biotechs.
Oct 18, 2017 by Brian Feroldi, Travis Hoium, and John Rosevear3 Dividend Stocks Ideal for RetireesLooking for income in today's yield-starved world? Here's why these three stocks fit the bill.
Oct 17, 2017 by Brian FeroldiWhy Impax Laboratories Inc Is Tanking TodayTraders flee after the company announces that it is merging with a privately held drugmaker.
